JPMorgan Chase & Co’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-629,541
| Closed | -$9.43M | – | 4467 |
|
|
2016
Q2 | $9.43M | Sell |
629,541
-15,485
| -2% | -$232K | ﹤0.01% | 1667 |
|
|
2016
Q1 | $7.85M | Sell |
645,026
-53,868
| -8% | -$655K | ﹤0.01% | 1719 |
|
|
2015
Q4 | $11.1M | Buy |
698,894
+10,365
| +2% | +$165K | ﹤0.01% | 1538 |
|
|
2015
Q3 | $10.6M | Sell |
688,529
-7,833
| -1% | -$120K | ﹤0.01% | 1531 |
|
|
2015
Q2 | $16.9M | Sell |
696,362
-25,963
| -4% | -$631K | ﹤0.01% | 1355 |
|
|
2015
Q1 | $16.8M | Sell |
722,325
-20,365
| -3% | -$473K | ﹤0.01% | 1415 |
|
|
2014
Q4 | $18.6M | Buy |
742,690
+74,252
| +11% | +$1.86M | ﹤0.01% | 1339 |
|
|
2014
Q3 | $20.8M | Sell |
668,438
-6,568
| -1% | -$204K | ﹤0.01% | 1251 |
|
|
2014
Q2 | $17.5M | Sell |
675,006
-44,023
| -6% | -$1.14M | ﹤0.01% | 1397 |
|
|
2014
Q1 | $16.8M | Buy |
719,029
+21,507
| +3% | +$503K | ﹤0.01% | 1406 |
|
|
2013
Q4 | $17.7M | Sell |
697,522
-318,621
| -31% | -$8.09M | 0.01% | 1318 |
|
|
2013
Q3 | $20.7M | Sell |
1,016,143
-22,510
| -2% | -$459K | 0.01% | 1235 |
|
|
2013
Q2 | $21.8M | Buy |
+1,038,653
| New | +$21.8M | 0.01% | 1127 |
|